Abivax SA bags €49.2m to push ABX-464Paris-based Abivax SA has cashed in €49.2m in an oversubscribed financing with top-tier US and European biotech investors. more ➔
BioEcho Life Sciences launches US subsidia...German nucleic acid extraction specialist BioEcho Life Sciences has opened a subsidiary in Boston to supply the huge US-american market. more ➔ more ➔
Belgian researchers create extraembryonic...Researchers from KU Leuven for the first time have produced human cells able to mimic the molecular mechanisms of early human embryogenesis and related defects. more ➔
SARS-CoV-2 infection triggers chronic fati...A small prospective study among mid-aged people has demonstrated that a mild SARS-CoV-2 infection triggers ME/CF in 50% of the study population.<button lang="en-GB" aria-description="Klicken, … more ➔
Danish Bactolife A/S grabs fundingSwedish food and feed supplement specialist Bactolife A/S has received US$5m in funding from the Bill & Melinda Gates Foundation to address gastrointestinal infections. more ➔
Moderna launches patent dispute with BioNT...For the second time within a short period of time, a competitor has sued the mRNA vaccine developer BioNtechPfizer for patent infringement. more ➔
Belgian eTheRNA raises €39m in Series B2...Moderna co-founder Kenneth Chien and Novalis LifeSciences LLC are the lead investors of a €39m Series B2 financing in eTheRNA. more ➔
Kinarus announces CHF 20 million convertib...Kinarus Therapeutics Holding AG has raised US$20m in financing through the issuance of convertible bonds to YA II PN, Ltd. more ➔
Cancer: Western life style is a killerA study in the scientific journal The Lancet shows that half of all global cancer deaths are due to life style-related risk factors such as smoking and alcohol use. more ➔
Ryvu Therapeutics bags €22m from EIB Polish cancer drug developer, Ryvu Therapeutics, has received €22m funding from the European Investment Bank via its venture debt instrument. more ➔
